Recent submissions

Comment · 4 years ago
Comment · 4 years ago
Comment · 4 years ago
abelacimab in particular was quite worrying. The BMJ (the journal OP posted) contained a criticism of that.

Similarly as you say is that because numbers are easy to think about antibody titres somehow took over the world when it came to covid vaccination. Despite good evidence t-cell activity is important for preventing severe disease.

Comment · 4 years ago
I'm not sure what part of what I said you disagree with.

Nothing in the NICE guidelines explains how ECT works - because like the rest of the world NICE does not know.

Once odd aspect with ECT is that it seems to transiently improve parkinson's, again no one knows why.

Comment · 4 years ago
We also don't know who CBT works for what it's worth.

It's also fairly limited in suitability (good luck with someone with catatonic depression trying to get them do a hot cross bun), availability (thankfully online therapies are more common now, but it takes 2 mins a day to take a pill and about an hour per week for CBT), affordability (a year of sertraline will cost less than the initial session of session of CBT can).

Comment · 4 years ago
An extra foible is that many medications have psychiatric side effects.

So even if you're prescribed a statin for the biochemical effect on cholesterol you might get some of the purported psychiatric effects.

Comment · 4 years ago
The interesting bits, for me, are the imaging scans which are expensive and slow and you need more than one for comparison per subject.

Secondly the 'covert treatment' aspect, and as far as I know only Hjorth et al. do in any reasonable numbers is the giving someone the treatment and usual and tell them it's a placebo and they "shouldn't expect to get better".

It's ethically tricky to do that with an anxiety disorder but I imagine a doctor telling someone with depression that will be painfully close to "you're not getting better", "we're not going to help you" and other quite rejecting disheartening ideas.

But plain placebo controlled SSRI trials I think show about a 0.2 absolute benefit in SSRIs in depression. i.e. if you compare SSRI with placebo you need to treat 5 people with SSRI to see one more person respond. If you compare SSRI with no treatment, you only need to treat 3 people with depression, to have 1 more respond. Those 3 and 5 are called the 'number needed to treat' and can be compared to the 'number needed to harm'.

Comment · 4 years ago
Comment · 4 years ago
It's a shame that the imagining is so expensive, because I'd love to see a true control arm with placebos and follow up scans.

i.e. if you are on a placebo and are told you will get better how many do?

Comment · 4 years ago
Comment · 4 years ago
> Other clinicians say, however, that the notion of depression being because of a simple chemical imbalance is outmoded anyway, and that antidepressants remain a useful option for patients alongside other approaches including talking therapies.

This is the key line in the summary.

The concept of attacking an idea no one really believes is really a straw man.

More importantly the modern practice of medicine is "evidence based medicine", not "mechanism based medicine". That means treatments are tested as to if they work, not how they work. Ideally in multiple well run double blinded randomised controlled trials with at least some against treatment as usual. Unlike the past when we thought more about how they might work, theorising something is off about someone's humors and adjusting with leeches.

Anyone looking for a truly mind bending result should look at Hjorth et al. 2021 [0], the study recruited people with social phobia and gave them all an SSRI (escitalopram). Half were told they were getting a sham active placebo and "should not expect to get better", half were told "you're getting the known effective treatment".

Headline result being told you are being treated leads to 4x as much response with brain changes in the dopamin networks.

In the meanwhile, rather than worry about how antidepressants work, why not take a look at electroconvulsive therapy which has proven time and again to be the most effective treatment for depression. Yet we have no idea how it works, other than knowing a decent seizure in those without epilepsy makes you less sad? What on earth.

[0] https://www.nature.com/articles/s41398-021-01682-3

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton